Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands

被引：1

作者：

Zhong, Hui ^{[1
]}

Jiang, Qi ^{[1
]}

Wu, Cong ^{[1
]}

Yu, Huanghe ^{[1
,2
]}

Li, Bin ^{[1
,2
]}

Zhou, Xudong ^{[1
,2
]}

Fu, Ronggeng ^{[1
]}

Wang, Wei ^{[1
,2
]}

Sheng, Wenbing ^{[1
,2
]}

机构：

[1] Hunan Univ Chinese Med, Sch Pharm, Changsha 410208, Peoples R China

[2] Hunan Univ Chinese Med, TCM & Ethnomed Innovat & Dev Int Lab, Changsha 410208, Peoples R China

来源：

MOLECULES | 2024年 / 29卷 / 02期

关键词：

artemisinin; bivalent ligands; multi-target molecular docking; antitumor target protein; antitumor activity; BRIDGED PORPHYRINS; IN-VITRO; CANCER; ANTIMALARIAL; DERIVATIVES; POTENT; DIMERS; BCL-2; MECHANISMS; EXPRESSION;

D O I：

10.3390/molecules29020409

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Five artemisinin bivalent ligands molecules 4a-4e were designed, synthesized, and confirmed by 1H NMR, 13C NMR, and low-resolution mass spectrometry, and the bioactivities of the target compounds were investigated against four human tumor cell lines in vitro, including BGC-823, HepG-2, MCF-7, and HCT-116. The results showed 4a, 4d, and 4e exhibited significantly tumor cell inhibitory activity compared with the artemisinin and dihydroartemisinin; compound 4e has good biological activity inhibiting BGC-823 with an IC50 value of 8.30 mu mol/L. Then, the good correlations with biological results were validated by molecular docking through the established bivalent ligands multi-target model, which showed that 4e could bind well with the antitumor protein MMP-9.

引用

页数：14

共 50 条

[21] Design, synthesis and antitumor activity evaluation of novel benzamide HDAC inhibitors
Cai, Ci
Luan, Yepeng
MEDICINAL CHEMISTRY RESEARCH, 2024, 33 (05) : 748 - 763
[22] Design, synthesis, and antitumor activity evaluation of novel acyl sulfonamide spirodienones
Chen, Chen
Luo, Yang
Yin, Honglu
Zhong, Qiu
Zheng, Shilong
Liu, Rui
Zhao, Chong
Wang, Guangdi
He, Ling
BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 60
[23] Design, Synthesis and Activity Evaluation of Novel Bivalent HIV-1 Fusion Inhibitor
Ling Yan-Bo
Wang Kun
Jiang Xi-Feng
Cai Li-Feng
Liu Ke-Liang
CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2013, 34 (09): : 2102 - 2107
[24] Design, synthesis, and characterization of potential bivalent ligands for histamine receptors.
Buszek, KR
Baures, PW
Malik, OP
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U205 - U205
[25] Design, synthesis and antitumor activity evaluation of benzimidazole derivatives with potent HDAC inhibitory activity
Ping, Jiantao
Chu, Hongrui
Zhao, Yisheng
Chen, Chen
MEDICINAL CHEMISTRY RESEARCH, 2025, 34 (02) : 445 - 454
[26] Design, synthesis, and antitumor activity evaluation of carbazole derivatives with potent HDAC inhibitory activity
Sun, Likun
Han, Leiqiang
Zhang, Liang
Chen, Chen
Zheng, Chengyun
MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (08) : 1677 - 1689
[27] Design, synthesis, and antitumor activity evaluation of carbazole derivatives with potent HDAC inhibitory activity
Likun Sun
Leiqiang Han
Liang Zhang
Chen Chen
Chengyun Zheng
Medicinal Chemistry Research, 2023, 32 : 1677 - 1689
[28] Design, synthesis and biological evaluation of bivalent ligands against A1–D1 receptor heteromers
Jian Shen
Lei Zhang
Wan-ling Song
Tao Meng
Xin Wang
Lin Chen
Lin-yin Feng
Ye-chun Xu
Jing-kang Shen
Acta Pharmacologica Sinica, 2013, 34 : 441 - 452
[29] Design, synthesis and biological evaluation of bivalent benzoxazolone and benzothiazolone ligands as potential anti-inflammatory/analgesic agents
Abdelazeem, Ahmed H.
Khan, Shabana I.
White, Stephen W.
Sufka, Kenneth J.
McCurdy, Christopher R.
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (13) : 3248 - 3259
[30] Design, Synthesis and Biological Evaluation of Bivalent Ligands with μ/δ Opioid Agonist (μ-preferring)/NK-1 Antagonist Activities
Giri, Aswini Kumar
Xie, Q.
Davis, P.
Vargas, E.
Rankins, D.
Porrecas, F.
Lai, J. Y.
Hruby, V. J.
BIOPOLYMERS, 2013, 100 (03) : 250 - 250

← 1 2 3 4 5 →